EP3409270
Þurrduftsamsetning sem inniheldur andkólínvirkt lyf, barkstera og beta-adrenavirkt lyf til gjafar með innöndun.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.7.2014EP published:
24.2.2021EP application number:
18178893.6
EP translation filed:
20.4.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
9.7.2034Expiry date:
9.7.2026Next due date:
31.7.2026
Title:
DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC FOR ADMINISTRATION BY INHALATION
Timeline
Today
10.7.2014EP application
24.2.2021EP Publication
20.4.2021Translation submitted
15.5.2021Registration published
9.7.2026Expires
Owner
Name:
Chiesi Farmaceutici S.p.A.Address:
Via Palermo 26/A, 43122 Parma, IT
Inventor
Name:
MUSA, RossellaAddress:
43100 Parma, IT
Name:
PASQUALI, IreneAddress:
43100 Parma, IT
Name:
ASKEY-SARVAR, AzitaAddress:
43100 Parma, IT
Name:
SCHIARETTI, FrancescaAddress:
43100 Parma, IT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13176114Date:
11.7.2013Country:
EP
Number:
13194763Date:
28.11.2013Country:
EP
Classification
Categories:
A61K 9/00, A61K 47/12, A61K 47/26, A61K 31/167, A61K 31/40, A61K 31/573
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 18.6.2021
Expires: 9.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 21.6.2022
Expires: 9.7.2023
Payer: Patice ehf.
Number: 10
Paid: 11.7.2023
Expires: 9.7.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 18.6.2024
Expires: 9.7.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 4.7.2025
Expires: 9.7.2026
Payer: Árnason Faktor ehf.